drugset / Trial / NCT04135833
A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711
Non-randomizedParallel-groupOpen-labelOther
Summary
This is a phase I study to assess the effect of itraconazole and rifampicin on the pharmacokinetic parameters of BPI-7711 in Chinese healthy volunteers.
Timeline
- Start
- 2019-12-12
- Primary completion
- 2020-07-22
- Completion
- 2020-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 200 mg | — |
| Subject | Rifampin | Small molecule | 600 mg | — |
| Subject | rezivertinib | Small molecule | 60 mg | — |
| Subject | rezivertinib | Small molecule | 180 mg | — |